Robert E Goldsby

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group
    Robert E Goldsby
    University of California San Francisco, Benioff Children s Hospital, San Francisco, CA, United States
    Eur J Cancer 49:2384-91. 2013
  2. pmc Survivors of childhood cancer have increased risk of gastrointestinal complications later in life
    Robert Goldsby
    Pediatric Hematology Oncology, UCSF Benioff Children s Hospital, San Francisco, California, USA
    Gastroenterology 140:1464-71.e1. 2011
  3. ncbi request reprint Surviving childhood cancer; now what? Controversies regarding long-term follow-up
    Robert E Goldsby
    Pediatric Oncology, UCSF Box 0106, San Francisco, CA 94143 0106, USA
    Pediatr Blood Cancer 43:211-4. 2004
  4. pmc Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study
    Robert E Goldsby
    UCSF Pediatric Oncology, 505 Parnassus Ave, Box 0106, San Francisco, CA 94143 0106, USA
    J Clin Oncol 28:324-31. 2010
  5. ncbi request reprint Surviving childhood cancer: the impact on life
    Robert E Goldsby
    Division of Pediatric Hematology Oncology, University of California, San Francisco, USA
    Paediatr Drugs 8:71-84. 2006
  6. pmc Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study
    Sabine Mueller
    Department of Neurology, Pediatrics and Neurosurgery, University of California, San Francisco, San Francisco, California 94158, USA
    Int J Radiat Oncol Biol Phys 86:649-55. 2013
  7. ncbi request reprint Survival after recurrence of osteosarcoma: a 20-year experience at a single institution
    Brian D Crompton
    Department of Pediatrics, UCSF Children s Hospital, San Francisco, California 94143 0106, USA
    Pediatr Blood Cancer 47:255-9. 2006
  8. pmc Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis
    Erin E Karski
    Department of Pediatrics, UCSF School of Medicine, San Francisco, CA 94143 0106, USA
    Cancer Epidemiol 37:29-33. 2013
  9. ncbi request reprint Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG)
    Paul A Fitzgerald
    Department of Medicine, UCSF Comprehensive Cancer Center, Box 1222, University of California, San Francisco, San Francisco, CA 94143 1222, USA
    Ann N Y Acad Sci 1073:465-90. 2006
  10. ncbi request reprint Seeding of osteosarcoma in the biopsy tract of a patient with multifocal osteosarcoma
    Kriengkrai Iemsawatdikul
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Pediatr Radiol 35:717-21. 2005

Collaborators

Detail Information

Publications17

  1. pmc Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group
    Robert E Goldsby
    University of California San Francisco, Benioff Children s Hospital, San Francisco, CA, United States
    Eur J Cancer 49:2384-91. 2013
    ..This study assessed the maximum tolerated dose (MTD) and the feasibility of ZA when combined with chemotherapy in patients with metastatic OS...
  2. pmc Survivors of childhood cancer have increased risk of gastrointestinal complications later in life
    Robert Goldsby
    Pediatric Hematology Oncology, UCSF Benioff Children s Hospital, San Francisco, California, USA
    Gastroenterology 140:1464-71.e1. 2011
    ..However, the long-term GI consequences have not been extensively studied. We evaluated the incidence of long-term GI outcomes and identified treatment-related risk factors...
  3. ncbi request reprint Surviving childhood cancer; now what? Controversies regarding long-term follow-up
    Robert E Goldsby
    Pediatric Oncology, UCSF Box 0106, San Francisco, CA 94143 0106, USA
    Pediatr Blood Cancer 43:211-4. 2004
  4. pmc Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study
    Robert E Goldsby
    UCSF Pediatric Oncology, 505 Parnassus Ave, Box 0106, San Francisco, CA 94143 0106, USA
    J Clin Oncol 28:324-31. 2010
    ..Little is known about the incidence and severity of late-occurring neurologic sequelae in ALL survivors. Data were analyzed to determine the incidence of adverse long-term neurologic outcomes and treatment-related risk factors...
  5. ncbi request reprint Surviving childhood cancer: the impact on life
    Robert E Goldsby
    Division of Pediatric Hematology Oncology, University of California, San Francisco, USA
    Paediatr Drugs 8:71-84. 2006
    ..Guidelines for long-term follow-up have been established and are available to help facilitate appropriate monitoring of and care for potential late effects...
  6. pmc Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study
    Sabine Mueller
    Department of Neurology, Pediatrics and Neurosurgery, University of California, San Francisco, San Francisco, California 94158, USA
    Int J Radiat Oncol Biol Phys 86:649-55. 2013
    ..To test the hypotheses that (1) the increased risk of stroke conferred by childhood cranial radiation therapy (CRT) persists into adulthood; and (2) atherosclerotic risk factors further increase the stroke risk in cancer survivors...
  7. ncbi request reprint Survival after recurrence of osteosarcoma: a 20-year experience at a single institution
    Brian D Crompton
    Department of Pediatrics, UCSF Children s Hospital, San Francisco, California 94143 0106, USA
    Pediatr Blood Cancer 47:255-9. 2006
    ..We present findings in 59 patients treated at our institution from 1974 to 1996 who have relapsed one or more times after their initial response...
  8. pmc Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis
    Erin E Karski
    Department of Pediatrics, UCSF School of Medicine, San Francisco, CA 94143 0106, USA
    Cancer Epidemiol 37:29-33. 2013
    ..The peak incidence of Ewing sarcoma (EWS) is in adolescence, with little known about patients who are ≥40 years at diagnosis. We describe the clinical characteristics and survival of this rare group...
  9. ncbi request reprint Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG)
    Paul A Fitzgerald
    Department of Medicine, UCSF Comprehensive Cancer Center, Box 1222, University of California, San Francisco, San Francisco, CA 94143 1222, USA
    Ann N Y Acad Sci 1073:465-90. 2006
    ..For patients with metastatic PHEO or PGL, who have good *I-MIBG uptake on diagnostic scanning, high-dose 131I-MIBG therapy was effective in producing a sustained CR, PR, or SD in 67% of patients, with tolerable toxicity...
  10. ncbi request reprint Seeding of osteosarcoma in the biopsy tract of a patient with multifocal osteosarcoma
    Kriengkrai Iemsawatdikul
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Pediatr Radiol 35:717-21. 2005
    ..We report a case of multifocal osteosarcoma in a 7-year-old boy who developed iatrogenic seeding of tumor along the biopsy tract. The results of the plain radiograph, CT, and histopathological correlation are presented...
  11. ncbi request reprint Patellar metastatic melanoma in a 13-year-old boy
    Thomas F Burk
    Department of Orthopaedic Surgery, University of California, San Francisco, USA
    Am J Orthop (Belle Mead NJ) 39:582-6. 2010
    ....
  12. pmc Osteoid osteoma of the femur in a 7-month-old infant treated with radiofrequency ablation
    Warapat Virayavanich
    Department of Radiology, University of California San Francisco, San Francisco, CA, USA
    Skeletal Radiol 39:1145-9. 2010
    ..In summary, this case report shows that osteoid osteoma can present in early infancy and can be successfully treated with RFA at this age, however, recurrence after the procedure can occur and close follow-up is recommended...
  13. ncbi request reprint Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors
    Lars M Wagner
    Division of Pediatric Hematology Oncology, University of Utah Primary Children s Medical Center, Salt Lake City, Utah, USA
    Clin Cancer Res 10:840-8. 2004
    ..The purpose is to estimate the maximum-tolerated dose (MTD) of temozolomide and irinotecan given on a protracted schedule in 28-day courses to pediatric patients with refractory solid tumors...
  14. doi request reprint Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma
    Elliot Stieglitz
    Department of Pediatric Hematology Oncology, UCSF Benioff Children s Hospital Department of Anatomic Pathology, Urology and Radiation Oncology, UCSF, San Francisco, CA
    J Pediatr Hematol Oncol 36:e57-60. 2014
    ..The mixed response to chemotherapy was unusual and the decision was made to resect one of the growing lesions. Fungal culture from the excised lesion grew Coccidioides immitis. ..
  15. ncbi request reprint Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia
    Grace E Kim
    UCSF Children s Hospital, San Francisco, California 94143 0106, USA
    Pediatr Blood Cancer 45:57-9. 2005
    ..Second malignant neoplasms are relatively rare in survivors of ALL treated without radiation. Even more unusual is the development of Ewing sarcoma as the SMN...
  16. doi request reprint Receptor imaging of pediatric tumors: clinical practice and new developments
    Heike E Daldrup-Link
    Department of Radiology, University of California at San Francisco, San Francisco, CA 94131, USA
    Pediatr Radiol 38:1154-61. 2008
    ....
  17. pmc Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis
    Ranga N Venkatesan
    Department of Pathology, University of Washington, Seattle, WA 98195 7705, USA
    Mol Cell Biol 27:7669-82. 2007
    ....